Brain Aging and Treatment Response in Geriatric Depression
Status:
Completed
Trial end date:
2019-01-23
Target enrollment:
Participant gender:
Summary
The proposed project will evaluate the role of neuroimaging biomarkers of brain aging (i.e.,
neurodegenerative and vascular brain changes) and mild cognitive impairment in the patterns
of treatment response to memantine combined with escitalopram compared to escitalopram and
placebo.